Comparison of airway T cell phenotypes in COPD and severe asthma: the influence of smoking Source: Eur Respir J 2005; 26: Suppl. 49, 23s Year: 2005
Effect of corticosteroids on lymphocytes from severe asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
CD8+ve airway inflammation in COPD: The impact of smoking status Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work Year: 2003
Evidence of a distinct phenotype of adult onset asthma characterized by an airway neutrophilia and poor response to inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001
Systemic sensitivity to corticosteroids in smokers with asthma Source: Eur Respir J 2007; 29: 64-71 Year: 2007
Smoking, sputum cell counts, diffusion capacity and hyperinflation predict beneficial effects of long-term inhaled corticosteroids (ICS) on FEV1-decline in patients with mild-to-moderate COPD Source: Annual Congress 2010 - COPD: management Year: 2010
The influence of smoking on the treatment response in patients with asthma Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007
Effects of smoking on circulating and airway T-lymphocytes antigen expression in patients with COPD after radiation exposure Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020
Salmeterol treatment improves corticosteroid responsivness in patients with corticosteroid-insensitive severe asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005
Is omalizumab response influenced by passive smoking in severe asthma? Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018
Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006
Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005
The effect of high dose bronchodilators on cardiac function in elderly people with severe COPD or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002
The effects of long-term smoking on pre-existing asthma in mice Source: Eur Respir J 2004; 24: Suppl. 48, 253s Year: 2004
COPD and asthma: the effect of glucocorticosteroid therapy on tolerance to physical activity Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005
The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
The influence of smoking on the formation of cold airway hyperresponsiveness and destructive-cytolytic profile of goblet cells in asthma patients Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018